Healthy Skepticism Library item: 6584

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Lexchin J.
Re: the promotion of Arcalion (sulbutiamine) and Duxaril (almitrine/raubasine)
1995 May;

Abstract:

In the Philippines Servier is promoting Arcalion (sulbutiamine) or all forms of asthenia and Duxaril (almitrine/raubasine) for improving cerebral arterial oxygen content and providing major benefit in cerebral, visual and ear/nose/throat symptoms. The scientific literature does not support these claims.

Keywords:
*analysis/Philippines/developing countries/sulbutiamine/Arcalion/Duxaril/almitrine/raubasine/quality of information/safety & risk information/Servier/neurologic drugs/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: NEUROLOGIC DISEASES